======= MANBA =======
== Gene Information ==
* **Official Symbol**: MANBA
* **Official Name**: mannosidase beta
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4126|4126]]
* **UniProt**: [[https://www.uniprot.org/uniprot/O00462|O00462]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=MANBA&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MANBA|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/609489|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a member of the glycosyl hydrolase 2 family. The encoded protein localizes to the lysosome where it is the final exoglycosidase in the pathway for N-linked glycoprotein oligosaccharide catabolism. Mutations in this gene are associated with beta-mannosidosis, a lysosomal storage disease that has a wide spectrum of neurological involvement. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: Exoglycosidase that cleaves the single beta-linked mannose residue from the non-reducing end of all N-linked glycoprotein oligosaccharides.
|Glyco hydro 2 N|
|Glyco hydro 2 C|
|cell wall polysaccharide catabolic process|
|beta-mannosidase activity|
|mannan metabolic process|
|mannan catabolic process|
|cell wall polysaccharide metabolic process|
|cell wall macromolecule catabolic process|
|cell wall macromolecule metabolic process|
|cell wall organization or biogenesis|
|oligosaccharide catabolic process|
|cellular polysaccharide catabolic process|
|polysaccharide catabolic process|
|mannose binding|
|glycoprotein catabolic process|
|cellular carbohydrate catabolic process|
|oligosaccharide metabolic process|
|azurophil granule membrane|
|cellular polysaccharide metabolic process|
|polysaccharide metabolic process|
|lysosomal lumen|
|carbohydrate catabolic process|
|cellular carbohydrate metabolic process|
|carbohydrate derivative catabolic process|
|lysosome|
|glycoprotein metabolic process|
|carbohydrate metabolic process|
|neutrophil degranulation|
|neutrophil activation involved in immune response|
|neutrophil mediated immunity|
|neutrophil activation|
|granulocyte activation|
|leukocyte degranulation|
|myeloid leukocyte mediated immunity|
|myeloid cell activation involved in immune response|
|myeloid leukocyte activation|
|leukocyte activation involved in immune response|
|cell activation involved in immune response|
|protein catabolic process|
|intracellular membrane-bounded organelle|
|regulated exocytosis|
|leukocyte mediated immunity|
|exocytosis|
|cellular macromolecule catabolic process|
|leukocyte activation|
|secretion by cell|
|carbohydrate derivative metabolic process|
|export from cell|
|macromolecule catabolic process|
|organonitrogen compound catabolic process|
|cell activation|
|immune effector process|
|secretion|
|organic substance catabolic process|
|cellular catabolic process|
|immune response|
|vesicle-mediated transport|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|1.72|
|[[:results:exp53|Suberoylanilide-Hydroxamic-Acid 0.02μM R01 exp53]]|1.79|
|[[:results:exp40|2-Methoxyestradiol 0.2μM R01 exp40]]|1.82|
|[[:results:exp61|YM155 0.0002μM R01 exp61]]|1.9|
|[[:results:exp123|GSK-LSD1 10μM R03 exp123]]|2.05|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 17288
* **Expression level (log2 read counts)**: 5.55
{{:chemogenomics:nalm6 dist.png?nolink |}}